Japan Age Related Macular Degeneration Drug Market Report 2016

Publisher Name :
Date: 15-Sep-2016
No. of pages: 119
Inquire Before Buying

Notes:

Sales, means the sales volume of Age Related Macular Degeneration Drug

Revenue, means the sales value of Age Related Macular Degeneration Drug

This report studies sales (consumption) of Age Related Macular Degeneration Drug in Japan market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Roche/Genentech

- Novartis

- Regeneron

- Bayer

- Valeant

- Allergan

- Alimera Sciences

- Ophthotech

- Acucela

- Ohr Pharmaceuticals

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Age Related Macular Degeneration Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

Japan Age Related Macular Degeneration Drug Market Report 2016

Table of Contents
Japan Age Related Macular Degeneration Drug Market Report 2016
1 Age Related Macular Degeneration Drug Overview
1.1 Product Overview and Scope of Age Related Macular Degeneration Drug
1.2 Classification of Age Related Macular Degeneration Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Age Related Macular Degeneration Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Japan Market Size Sales (Value) and Revenue (Volume) of Age Related Macular Degeneration Drug (2011-2021)
1.4.1 Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2021)
1.4.2 Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)
2 Japan Age Related Macular Degeneration Drug Competition by Manufacturers
2.1 Japan Age Related Macular Degeneration Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 Japan Age Related Macular Degeneration Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 Japan Age Related Macular Degeneration Drug Average Price by Manufactures (2015 and 2016)
2.4 Age Related Macular Degeneration Drug Market Competitive Situation and Trends
2.4.1 Age Related Macular Degeneration Drug Market Concentration Rate
2.4.2 Age Related Macular Degeneration Drug Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 Japan Age Related Macular Degeneration Drug Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 Japan Age Related Macular Degeneration Drug Sales and Market Share by Type (2011-2016)
3.2 Japan Age Related Macular Degeneration Drug Revenue and Market Share by Type (2011-2016)
3.3 Japan Age Related Macular Degeneration Drug Price by Type (2011-2016)
3.4 Japan Age Related Macular Degeneration Drug Sales Growth Rate by Type (2011-2016)
4 Japan Age Related Macular Degeneration Drug Sales (Volume) by Application (2011-2016)
4.1 Japan Age Related Macular Degeneration Drug Sales and Market Share by Application (2011-2016)
4.2 Japan Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 Japan Age Related Macular Degeneration Drug Manufacturers Profiles/Analysis
5.1 Roche/Genentech
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Novartis
5.2.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Regeneron
5.3.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Bayer
5.4.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Valeant
5.5.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Allergan
5.6.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Alimera Sciences
5.7.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Ophthotech
5.8.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Acucela
5.9.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Ohr Pharmaceuticals
5.10.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Age Related Macular Degeneration Drug Manufacturing Cost Analysis
6.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Age Related Macular Degeneration Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 Japan Age Related Macular Degeneration Drug Market Forecast (2016-2021)
10.1 Japan Age Related Macular Degeneration Drug Sales, Revenue Forecast (2016-2021)
10.2 Japan Age Related Macular Degeneration Drug Sales Forecast by Type (2016-2021)
10.3 Japan Age Related Macular Degeneration Drug Sales Forecast by Application (2016-2021)
10.4 Age Related Macular Degeneration Drug Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Age Related Macular Degeneration Drug
Table Classification of Age Related Macular Degeneration Drug
Figure Japan Sales Market Share of Age Related Macular Degeneration Drug by Type in 2015
Table Application of Age Related Macular Degeneration Drug
Figure Japan Sales Market Share of Age Related Macular Degeneration Drug by Application in 2015
Figure Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2021)
Figure Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)
Table Japan Age Related Macular Degeneration Drug Sales of Key Manufacturers (2015 and 2016)
Table Japan Age Related Macular Degeneration Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Age Related Macular Degeneration Drug Sales Share by Manufacturers
Figure 2016 Age Related Macular Degeneration Drug Sales Share by Manufacturers
Table Japan Age Related Macular Degeneration Drug Revenue by Manufacturers (2015 and 2016)
Table Japan Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Japan Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table 2016 Japan Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table Japan Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Japan Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers in 2015
Figure Age Related Macular Degeneration Drug Market Share of Top 3 Manufacturers
Figure Age Related Macular Degeneration Drug Market Share of Top 5 Manufacturers
Table Japan Age Related Macular Degeneration Drug Sales by Type (2011-2016)
Table Japan Age Related Macular Degeneration Drug Sales Share by Type (2011-2016)
Figure Japan Age Related Macular Degeneration Drug Sales Market Share by Type in 2015
Table Japan Age Related Macular Degeneration Drug Revenue and Market Share by Type (2011-2016)
Table Japan Age Related Macular Degeneration Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Type (2011-2016)
Table Japan Age Related Macular Degeneration Drug Price by Type (2011-2016)
Figure Japan Age Related Macular Degeneration Drug Sales Growth Rate by Type (2011-2016)
Table Japan Age Related Macular Degeneration Drug Sales by Application (2011-2016)
Table Japan Age Related Macular Degeneration Drug Sales Market Share by Application (2011-2016)
Figure Japan Age Related Macular Degeneration Drug Sales Market Share by Application in 2015
Table Japan Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)
Figure Japan Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)
Table Roche/Genentech Basic Information List
Table Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche/Genentech Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Regeneron Basic Information List
Table Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regeneron Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Alimera Sciences Basic Information List
Table Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alimera Sciences Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Ophthotech Basic Information List
Table Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ophthotech Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Acucela Basic Information List
Table Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acucela Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Ohr Pharmaceuticals Basic Information List
Table Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure Age Related Macular Degeneration Drug Industrial Chain Analysis
Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015
Table Major Buyers of Age Related Macular Degeneration Drug
Table Distributors/Traders List
Figure Japan Age Related Macular Degeneration Drug Production and Growth Rate Forecast (2016-2021)
Figure Japan Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2016-2021)
Table Japan Age Related Macular Degeneration Drug Production Forecast by Type (2016-2021)
Table Japan Age Related Macular Degeneration Drug Consumption Forecast by Application (2016-2021)
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies [...]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new [...]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating [...]
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Global Andrographis Paniculata Extract Market Professional Survey Report 2017
    Published: 20-Apr-2017        Price: US 3500 Onwards        Pages: 114
    This report studies Andrographis Paniculata Extract in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Sabinsa - Bioprex - Gurjar Phytochem - Mother Herbs......
  • Global Antithrombotic Drugs Market Professional Survey Report 2017
    Published: 20-Apr-2017        Price: US 3500 Onwards        Pages: 109
    This report studies Antithrombotic Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Sanofi - Bayer - Boehringer Ingelheim - Genentech......
  • Global Bromhexine Market Professional Survey Report 2017
    Published: 20-Apr-2017        Price: US 3500 Onwards        Pages: 127
    This report studies Bromhexine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Sanofi Aventis - Teva - Boehringer Ingelheim - Novartis - Mylan......
  • Global Wolfberry Market Professional Survey Report 2017
    Published: 20-Apr-2017        Price: US 3500 Onwards        Pages: 101
    This report studies Wolfberry in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Ningxia Zaokang - Bairuiyuan Gouri Corp - Qitianxia - Ninganpu - Ni......
  • Global Black Chinese Wolfberry Market Professional Survey Report 2017
    Published: 20-Apr-2017        Price: US 3500 Onwards        Pages: 105
    This report studies Black Chinese Wolfberry in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - GODPOWER - Bairuiyuan Gouri Corp - Ninganpu - Ningxia Wolfb......
  • Global Insomnia Drugs Market Professional Survey Report 2017
    Published: 20-Apr-2017        Price: US 3500 Onwards        Pages: 117
    This report studies Insomnia Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Eisai - Merck - Pfizer - Sanofi - Takeda - Astellas......
  • China Polypeptide GalNac Transferase 1/GALNT1 Market Research Report 2017
    Published: 20-Apr-2017        Price: US 3200 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Polypeptide GalNac Transferase 1/GALNT1 Revenue, means the sales value of Polypeptide GalNac Transferase 1/GALNT1 This report studies Polypeptide GalNac Transferase 1/GALNT1 in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - R&D Systems - Thermo Fisher Scientific - Abcam - Abbexa - Abbiotec......
  • China GALNT3 Market Research Report 2017
    Published: 20-Apr-2017        Price: US 3200 Onwards        Pages: 107
    Notes: Sales, means the sales volume of GALNT3 Revenue, means the sales value of GALNT3 This report studies GALNT3 in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - R&D Systems - Thermo Fisher Scientific - Abcam - Abbexa - Abbiotec - Abgent - Abnova - antibodies-online - Assay Biotechnology - Avi......
  • China GALNT2 Market Research Report 2017
    Published: 20-Apr-2017        Price: US 3200 Onwards        Pages: 106
    Notes: Sales, means the sales volume of GALNT2 Revenue, means the sales value of GALNT2 This report studies GALNT2 in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - R&D Systems - Thermo Fisher Scientific - Abcam - Abbexa - Abbiotec - Abgent - Abnova - antibodies-online - Assay Biotechnology - Avi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs